These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3775768)

  • 1. Serum Erythropoietin levels and inhibitors of erythropoiesis in patients with chronic renal failure.
    Fukushima Y; Fukuda M; Yoshida K; Yamaguchi A; Nakamoto Y; Miura AB; Harada T; Tsuchida S
    Tohoku J Exp Med; 1986 Sep; 150(1):1-15. PubMed ID: 3775768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease.
    McGonigle RJ; Boineau FG; Beckman B; Ohene-Frempong K; Lewy JE; Shadduck RK; Fisher JW
    J Lab Clin Med; 1985 Apr; 105(4):449-58. PubMed ID: 3981057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failure.
    McGonigle RJ; Husserl F; Wallin JD; Fisher JW
    Kidney Int; 1984 Feb; 25(2):430-6. PubMed ID: 6727138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum erythropoietin (ESF) titers in anemia of chronic renal failure.
    de Klerk G; Wilmink JM; Rosengarten PC; Vet RJ; Goudsmit R
    J Lab Clin Med; 1982 Nov; 100(5):720-34. PubMed ID: 7130829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
    Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
    Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis.
    Shih LY; Huang JY
    Nephron; 1998; 79(2):142-7. PubMed ID: 9647492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency.
    McGonigle RJ; Wallin JD; Shadduck RK; Fisher JW
    Kidney Int; 1984 Feb; 25(2):437-44. PubMed ID: 6727139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of spermine as an inhibitor of erythropoiesis in patients with chronic renal failure.
    Radtke HW; Rege AB; LaMarche MB; Bartos D; Bartos F; Campbell RA; Fisher JW
    J Clin Invest; 1981 Jun; 67(6):1623-9. PubMed ID: 7240411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anemia of end-stage renal disease: hematopoietic progenitor cell response.
    Segal GM; Eschbach JW; Egrie JC; Stueve T; Adamson JW
    Kidney Int; 1988 May; 33(5):983-8. PubMed ID: 3392887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia of chronic renal failure: inhibition of erythropoiesis by uremic serum.
    Freedman MH; Cattran DC; Saunders EF
    Nephron; 1983; 35(1):15-9. PubMed ID: 6888621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of erythroid inhibiting factors (EIF) in patients with anemia of chronic renal failure.
    Radtke HW; Rege AB; LaMarche M; Fisher JW
    Proc Clin Dial Transplant Forum; 1979; 9():179-83. PubMed ID: 552040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma erythropoietin and hematocrit under the influence of chronic hemodialysis treatment (author's transl)].
    Schulz E; Mödder B; Rath K
    Klin Wochenschr; 1977 Jan; 55(2):65-9. PubMed ID: 834018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of different modes of dialysis on serum erythropoietin levels in pediatric patients. A report of the Southwest Pediatric Nephrology Study Group.
    Beckman BS; Brookins JW; Shadduck RK; Mangan KF; Deftos LJ; Fisher JW
    Pediatr Nephrol; 1988 Oct; 2(4):436-41. PubMed ID: 3153056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyamines in the anemia of end-stage renal disease.
    Kushner D; Beckman B; Nguyen L; Chen S; Della Santina C; Husserl F; Rice J; Fisher JW
    Kidney Int; 1991 Apr; 39(4):725-32. PubMed ID: 2051730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic inhibitors in chronic renal failure: lack of in vitro specificity.
    Delwiche F; Segal GM; Eschbach JW; Adamson JW
    Kidney Int; 1986 Mar; 29(3):641-8. PubMed ID: 3702219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of IFN-gamma and TNF-alpha.
    Allen DA; Breen C; Yaqoob MM; Macdougall IC
    J Investig Med; 1999 May; 47(5):204-11. PubMed ID: 10361379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of the anemia of renal insufficiency.
    Fisher JW; Foley JE; Moriyama Y; Ohno Y; Modder B; Lertora JJ
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():42-9. PubMed ID: 1029887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in erythropoiesis throughout a lifetime. Studies in a high-leukaemic mouse strain, the AKR/O strain, and a non-leukaemic strain, the WLO strain.
    Hellebostad M; Sanengen T; Halvorsen S
    Blut; 1990 Dec; 61(6):358-63. PubMed ID: 2291984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burst-promoting activity in the serum of patients with chronic renal failure undergoing long-term hemodialysis.
    Randall G; Meyer J; Swanepoel C; Jacobs P
    Stem Cells; 1993 Sep; 11(5):428-34. PubMed ID: 8241954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
    McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
    J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.